Synergistic antitumor cytotoxic actions of ascorbate and menadione on human prostate (DU145) cancer cells in Vitro: Nucleus and other injuries preceding cell death by autoschizis

Ultrastructural Pathology

Volumn 38, Issue 2, 2014, Pages 116-140

  Gilloteaux, Jacques ^a   Jamison, James M ^b   Neal, Deborah ^b   Summers, Jack L ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Summa Research Foundation   (United States)

Author keywords

Autoschizis; Carcinoma; Cell death; DU145; Nucleus; Organelles; Oxidative stress; Prostate

Indexed keywords

ASCORBIC ACID; MENADIONE;

ADENOCARCINOMA; ARTICLE; CELL DEATH; CELL NUCLEUS; CELL ORGANELLE; CYTOSKELETON; DRUG EFFECT; ELECTRON MICROSCOPY; HUMAN; MALE; PROSTATE TUMOR; TUMOR CELL LINE; ULTRASTRUCTURE;

ADENOCARCINOMA; ASCORBIC ACID; CELL DEATH; CELL LINE, TUMOR; CELL NUCLEUS; CYTOSKELETON; HUMANS; MALE; MICROSCOPY, ELECTRON; ORGANELLES; PROSTATIC NEOPLASMS; VITAMIN K 3;

EID: 84896780612     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913123.2013.852645     Document Type: Article

References (155)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61: 69-90.
2. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003;95: 1276-99.
3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63: 11-30.
4. Dall'Era MA, Albertsen PC, Bangma C, et al. Active surveillance for prostate cancer: A systematic review of the literature. Eur Urol 2012;62: 976-83.
5. Lees K, Durve M, Parker C. Active surveillance in prostate cancer: Patient selection and triggers for intervention. Curr Opin Urol 2012;22: 210-15.
6. Amaral TM, Macedo D, Fernandes I, Costa L. Castrationresistant prostate cancer: Mechanisms, targets, and treatment. Prostate Canc 2012;doi: 2012:327253.
7. Harris WP, Mostaghel EA, Nelson PS, Montgomery B. Androgen deprivation therapy: Progress in understanding mechanisms of resistance and optimizing androgen depletion. Nat Clin Pract Urol 2009;6: 76-85.
8. Paller CJ, Antonarakis ES. Cabazitaxel: A novel secondline treatment for metastatic castration-resistant prostate cancer. Drug Des Devel Ther 2011;5: 117-24.
9. Oudard S. Progress in emerging therapies for advanced prostate cancer. Cancer Treat Rev 2012;39: 275-89.
10. Taper HS. Evaluation of the validity of the histochemical lead nitrate technique for alkaline and acid deoxyribonuclease. J Histochem Cytochem 1979;27: 1483-90. (Pubitemid 10139261)
11. Taper HS. Altered deoxyribonuclease activity in cancer cells and its role in nontoxic adjuvant cancer therapy with mixed vitamins C and K3. Anticancer Res 2008;28: 2727-32.
12. Taper HS, de Gerlache J, Lans M, Roberfroid M. Non-toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pretreatment. Int J Cancer 1987;40: 575-9. (Pubitemid 17148749)
13. Taper HS, Roberfroid M. Non-toxic sensitization of cancer chemotherapy by combined vitamin and K3 pretreatment in a mouse tumor resistant to oncovin. Anticancer Res 1992; 12: 1651-4.
14. Taper HS, Keyeux A, Roberfroid M. Potentiation of radiotherapy by nontoxic pretreatment with combined vitanins C and K3 in mice bearing transplantable tumor. Anticancer Res 1996;16: 499-503. (Pubitemid 26128515)
15. Taper HS, Jamison JM, Gilloteaux J, et al. In vivo reactivation of DNases in implanted human prostate tumors after administration of a vitamin C: K3. J Histochem Cytochem 2001;49: 109-19. (Pubitemid 32012846)
16. Taper HS, Jamison JM, Gilloteaux J, et al. Inhibition of the development of metastases by dietary vitamin C: Vitamin K3 combination. Life Sci 2004;75: 955-67. (Pubitemid 38749255)
17. DeLoecker W, Janssens J, Bonte J, Taper HS. Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphtoquinone (vitamin K3) treatment on human tumor cell growth in vitro: II. Synergism with combined chemotherapy action. Anticancer Res 1993;13: 103-6. (Pubitemid 23118203)
18. Gilloteaux J, Jamison JM, Venugopal M, et al. Scanning electron microscopy and transmission electron microscopy aspects of synergistic antitumor activity of vitamin C-vitamin K3 combinations against human prostatic carcinoma cells. Scanning Mcrosc Intl 1995;9: 159-73.
19. Gilloteaux J, Jamison JM, Ervin E, et al. Cancer cell necrosis by autoschizis: Synergism of antitumor activity of vitamin C: Vitamin K3 on human bladder carcinoma T24 cells. Scanning 1998;20: 564-75. (Pubitemid 29031300)
20. Gilloteaux J, Jamison JM, Arnold D, Summers JL. Scanning electron microscope characteristics of human prostate adenocarcinoma cell line (DU145) transplanted in nude mice. Scanning 1999;21: 106-7.
21. Gilloteaux J, Jamison JM, Arnold D, Summers Jl. Autoschzis: Another cell death for cancer cells induced by oxidative stress. Ital J Anat Embryol 2001;106: 79-92.
22. Gilloteaux J, Jamison JM, Arnold D, et al. Ultrastructural aspects of autoschizis: A new cancer cell death induced by the synergistic action of ascorbate:menadione on human bladder carcinoma cells. Ultrastruct Pathol 2001;25: 183-92. (Pubitemid 32607291)
23. Gilloteaux J, Jamison JM, Arnold D, et al. Microscopic aspects of autoschizic cell death in human ovarian carcinoma (2774) cells following vitamin C, Vitamin K3 or vitamin C:K3 treatment. Microsc Microanal 2003;9: 311-29. (Pubitemid 37084346)
24. Gilloteaux J, Jamison JM, Arnold D, Summers JL. LM and SEM aspects of autoschizic cell death of ovarian carcinoma cells. Scanning 2003;25: 137-49.
25. Gilloteaux J, Jamison JM, Jarjoura D, et al. Autoschizis: A new form of cell death for human ovarian carcinoma cells following ascorbate: Menadione treatment. Nuclear and DNA degradation. Tissue Cell 2004;36: 197-209.
26. Gilloteaux J, Jamison JM, Arnold D, et al. Morphology and DNA degeneration during autoschizic cell death in bladder carcinoma T24 cells induced by ascorbate and menadione treatment. Anat Rec A Discov Mol Cell Evol Biol 2006;288: 58-83. (Pubitemid 43062594)
27. Gilloteaux J, Jamison JM, Neal DR, et al. Cell damage and death by autoschizis in human bladder (RT4) carcinoma cells resulting from treatment by ascorbate and menadione. Ultrastruct Pathol 2010;34: 140-60.
28. Gilloteaux J, Jamison JM, Arnold D, et al. Autoschizis: A new cell death induced found in tumour cells induced by oxidative stress mechanism. In: Mendez-Villas A, Alvarez JD, eds. Microscopy, science, technology, application and education. Bajadoz, Spain: Bajadoz, Spain, Formatex Research Center. Microscopy, 2011;1: 211-20.
29. Jamison JM, Gilloteaux J, Venugopal M, et al. Flow cytometric and ultrastructural aspects of the synergistic antitumor activity of vitamin C-vitamin K3 combinations against human prostatic carcinoma cells. Tissue Cell 1996; 28: 687-701. (Pubitemid 27011032)
30. Jamison JM, Gilloteaux J, Arnold D, Summers JL. SEM view of synergistic effects of vitamins C:K3 on DU 145 prostatic carcinoma cell line. Scanning 1999;21: 107-8.
31. Jamison JM, Gilloteaux J, Taper HS, Summers JL. Evaluation of the in vitro and in vivo antitumor activities of vitamin C and K3 combinations against human prostate cancer. J Nutr 2001;131: 158S-60S. (Pubitemid 32060639)
32. Jamison JM, Gilloteaux J, Taper HS, et al. Autoschizis: A novel cell death. Biochem Pharmacol 2002;63: 1773-83. (Pubitemid 34603442)
33. Jamison JM, Gilloteaux J, Nassiri MR, et al. Cell cycle arrest and autoschizis in a human bladder carcinoma cell line following vitamin C and vitamin K3 treatment. Biochem Pharmacol 2004;67: 337-51. (Pubitemid 38112764)
34. Jamison JM, Gilloteaux J, Perlaky L, et al. Nucleolar changes and fibrillarin, redistribution following Apatone-treatment of human bladder carcinoma cells. J Histochem Cytochem 2010;58: 635-51.
35. Venugopal M, Jamison JM, Gilloteaux J, et al. Synergistic antitumor activity of vitamins C and K3 on human urologic tumor cell lines. Life Sci 1996;59: 1389-400. (Pubitemid 26344373)
36. Venugopal M, Jamison JM, Gilloteaux J, et al. Synergistic antitumor activity of vitamins C and K 3 against human prostate carcinoma cell lines. Cell Biol Int 1996;20: 787-97. (Pubitemid 27075506)
37. Zhang W, Negoro T, Satoh KM, et al. Synergistic cytotoxic action of vitamin C and vitamin K3. Anaticancer Res 2001; 21: 3439-44.
38. Calderon PB, Caddrobbi J, Marques C, et al. Potential application of the association of vitamin C and K3 in cancer treatment. Curr Med Chem 2002;9: 2269-85.
39. Verrax J, Cadrobbi J, Delvaux M, et al. The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death. Basis for their potential use as adjuvants in anticancer therapy. Eur J Med Chem 2003;38: 451-7. (Pubitemid 36588911)
40. Gilloteaux J, Jamison JM, Neal DR, Summers JL. Xenotransplanted human prostate carcinoma (DU145) cells develop into carcinomas and cribriform carcinomas: Ultrastructural aspects. Ultrastruct Pathol 2012;36: 294-311.
41. Gilloteaux J, Jamison JM, McGuire K, et al. Autoschizis: A novel cell death induced in tumors by a new anticancer adjuvant or therapy. Royal Society of Medicine, Oncology Section. London Meeting on Translational Development against Cancer. 2012; 17 p. (abstract).
42. Gilloteaux J, Jamison JM, Arnold D, Summers JL. Human prostate DU145 carcinoma cells implanted in nude mice remove the peritoneal mesothelium to invade and grow as carcinomas. Anat Rec A Disc Mol Cell Evol Biol 2013;296: 40-55.
43. Jamison JM, Gilloteaux J, Taper HS, et al. The in vitro and in vivo antitumor activity of vitamin C: K3 combinations against prostate cancer. In: Lucas JL, ed. Trends in prostate cancer research. Hauppauge (NY): Nova Science, 2005:423-71.
44. Tareen B, Summers JL, Jamison JM, et al. A 12-week, open label, phase I/IIa study using Apatone-for the treatment of prostate cancer patients who have failed standard therapy. Int J Med Sci 2008;5: 62-7.
45. Gilloteaux J, Naud J. The zinc iodide-osmium tetroxide staining-fixative of Maillet. Nature of the precipitate studied by X-ray microanalysis and detection of Ca2\+-affinity subcellular sites in a tonic smooth muscle. Histochemistry 1979;63: 227-43.
46. Carruba G, Pavone C, Pavone-Macalusa M, et al. Morphometry of in vitro systems. An image analysis of two human prostate cancer cell lines (PC-3 and DU145). Pathol Res Prac 1989;185: 704-8. (Pubitemid 20076946)
47. Ren J. Relationship between development of microvilli on tumor cells and growth or metastatic potential of tumor cells. Hokkaido Igaku Zasshi 1991;66: 187-200.
48. Gonda MA, Aaronson SA, Ellmore N, et al. Ultrastructural studies of surface features of human normal and tumor cells in tissue culture by scanning and transmission electron microscopy. J Natl Cancer Inst 1976;56: 245-63.
49. Frost JK. The cell in health and disease. An evaluation of cellular morphologic expression of biologic behaviour, 2nd ed, revised. In: Wied JI, ed. Basel: Karger. Monogr Clin Cytol 1986;2: 1-304.
50. Srigley JR, Hartwick WJ. Selected ultrastructural aspects of urothelial and prostatic tumors. Ultrastruct Pathol 1988;12: 49-65. (Pubitemid 18052787)
51. Coene E, Van Oostveldt P, Willems K, et al. BRCA1 is localized in cytoplasmic tube-like invaginations in the nucleus. Nat Genet 1997;16: 122-4. (Pubitemid 27240610)
52. Burns ER, Soloff BL, Hanna C, Buxton DF. Nuclear pocket associated with the nucleolus in normal and neoplastic cells. Cancer Res 1971;31: 159-65.
53. Johnson N, Krebs M, Boudreau R, et al. Actin-filled nuclear invaginations indicate degree of cell de-differentiation. Differentiation 2003;71: 414-24. (Pubitemid 37249227)
54. Lagace TA, Ridgway ND. The rate-limiting enzyme in phosphatidylcholine synthesis regulates proliferation of the nucleoplasmic reticulum. Mol Biol Cell 2005;16: 1120-30. (Pubitemid 40349550)
55. Dahl KN, Ribeiro AJS, Lammerding J. Nuclear shape, mechanics, and mechanotransduction. Circ Res 2008;102: 1307-18.
56. Horesjsi B, Vinopal S, Stadkova V, et al. Nuclear g-tubulin associates with nucleoli and interacts with tumor suppressor protein C53. J Cell Physiol 2012;227: 367-82.
57. Clubb BH, Locke M. 3T3 cells have nuclear invaginations containing F-actin. Tissue Cell 1998;30: 684-91. (Pubitemid 29043771)
58. Bourgeois CA, Hubert J. Spatial relationship between the nucleolus and the nuclear envelope: Structural aspects and functional significance. Int Rev Cytol 1988;111: 1-52. (Pubitemid 19020189)
59. Bush H, Byvoet P, Smetana K. The nucleolus of the cancer cell: A review. Cancer Res 1963;23: 313-39.
60. Goessens G. Nucleolar structure. Int Rev Cytol 1984;87: 107-58.
61. Ras?ka I, Shaw PJ, Cmarko D. New insights into nucleolar architecture and activity. Int Rev Cytol 2006;255: 177-234.
62. Derenzini M, Betts CM, Ceccarelli C, Eusebi V. Ultrastructural organization of nucleoli in benign and malignant melanomas. Virchows Arch B Cell Pathol Incl Mol Pathol 1986;5: 342-52.
63. Kessel RG. Annulate lamellae: A last frontier in cellular organelles. Int Rev Cytol 1992;133: 43-120.
64. Bannash P. The cytoplasm of hepatocytes during carcinogenesis. In: Rentchnick P, ed. Recent results in cancer research. New York: Springer Verlag, Inc., 1968.
65. Podmore ID, Griffiths HR, Herbert KE, et al. Vitamin C exhibits pro-oxidant properties. Nature 1998;392: 559. (Pubitemid 28207702)
66. Gilloteaux J, Jamison JL, Neal DA, Summers JL. Cell death by autoschizis in TRAMP prostate carcinoma cells as a result of treatment by ascorbate: Menadione combination. Ultrastruct Pathol 2005;28: 221-36.
67. Lupulescu A. Ultrastructure and cell surface studies of cancer cells following vitamin C treatment. Exp Toxicol Pathol 1992;44: 3-9.
68. Koch CJ, Biaglow JE. Toxicity, radiation sensitivity modification and metabolic effects of dehydroxyascorbate and ascorbate in mammalian cells. J Cell Physiol 1978;94: 299-306. (Pubitemid 9095703)
69. Szent-Györgyi A. Observations on the function of peroxidase systems and the chemistry of the adrenal cortex: Description of a new carbohydrate derivative. Biochem J 1928;22: 1387-409.
70. Pedersen T, Aebi U. Nuclear actin extends, with no contraction in sight. Mol Biol Cell 2005;16: 5055-60. (Pubitemid 41566818)
71. Philomonenko W, Janácek J, Harata M, Hozák P. Transcription-dependent rearrangements of actin and nuclear myosin I in the nucleolus. Histochem Cell Biol 2010;134: 243-9.
72. Desai ID, Tappel AL. Damage to proteins by peroxidized lipids. J Lipid Res 1963;58: 204-7.
73. Maramag C, Menon M, Blaji KC, et al. Effect of vitamin C on prostate cancer cells in vitro: Effect on cell number, viability, and DNA synthesis. Prostate 1997;32: 188-95. (Pubitemid 27337953)
74. Orrenius S, McConkey DJ, Nicotera P. Role of calcium in toxic and programmed cell death. Adv Exp Med Biol 1991; 283: 419-25.
75. Farber JL, Kyle ME, Coleman JB. Mechanisms of cell injury by activating oxygen species. Lab Invest 1990;62: 670-9. (Pubitemid 20213684)
76. Sakagami H, Satoh K. Modulating factors of radical intensity and cytotoxic activity of ascorbate. Anticancer Res 1997;17: 3513-20. (Pubitemid 27522318)
77. Atkinson DE. The energy charge of the adenylate pool as a regulator parameter: Interaction with feedback modifiers. Biochemistry 1968;7: 4030-40.
78. Hernandez-Verdun D. Assembly and disassembly of the nucleolus during the cell cycle. Nucleus 2011;2: 189-94.
79. Jamison JM, Gilloteaux J, Koch JA, et al. Vitamin C and K3-induced oxidative stress in human prostate tumor cells: Mitochondrial ultrastructural alterations. Microsc Microanal 1997;3: 23-4.
80. Tardy C, Codogno P, Autefage H, et al. Lysosomes and lysosomal proteins in cancer cell death (new Players of an old struggle). Biochim Biophys Acta 2006;1765: 101-25.
81. McGuire K, Jamison JM, Neal D, et al. Elucidating the pathway of Apatone-induced DNase II reactivation during autoschizic cell death. Microsc Microanal 2009;15: 888-9.
82. Wu FY, Chang NT, Chen WJ, Juan CC. Vitamin K3-induced cell cycle arrest and apoptotic cell death are accompanied by altered expression of c-fos and c-myc in nasopharyngeal carcinoma cells. Oncogene 1993;8: 2237-44. (Pubitemid 23226958)
83. Wu FY, Liao WC, Chang HM. Comparison of antitumor activity of vitamins K1, K2 and K3 on human tumor cells by two (MTT and SRB) cell viability assays. Life Sci 1993;52: 1797-804.
84. Ngo E, Sun TP, Chang JY, et al. Menadione-induced damage in a human tumor cell line. Biochem Pharmacol 1991;41: 1283-92.
85. Dypbukt JM, Ankerona M, Burkitt M, et al. Different peroxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells. J Biol Chem 1997;269: 30553-60.
86. Markovits J, Sun TP, Juan CC, et al. Menadione (vitamin K3) enhances the mitogenic signal of epidermal growth factor via extracellular signal-regulated kinases. Int J Oncol 1998;13: 1163-70. (Pubitemid 28551539)
87. Bellomo G, Mirabelli F, Vairetti M, et al. Cytoskeleton as target in menadione-induced oxidative stress in cultured mammalian cells. Biochemical and immunocytochemical features. J Cell Physiol 1998;143: 118-28.
88. Napirei M, Wulf S, Mannherz HG. Chromatin breakdown during necrosis by serum Dnase1 and the plasminogen system. Arthritis Rheum 2004;50: 1873-83. (Pubitemid 38725100)
89. Gerasimenko JV, Gerasimenko OV, Palejwala A, et al. Menadione-induced apoptosis: Roles of cytosolic Ca2\+ elevations and the mitochondrial permeabilityu transition pore. J Cell Sci 2001;115: 485-97. (Pubitemid 34182976)
90. Osada S, Sakashima F, Hosona Y, et al. Extracellular signalregulated kinase phosphorylation due to menadioneinduced arylation mediates growth inhibition of pancreas cancer cells. Cancer Chemother Pharmacol 2008;62: 315-20. (Pubitemid 351692090)
91. Di Monte D, Bellomo G, Thor H, et al. Menadione-induced cytotoxicity is associated with protein thiol oxidation and alteration in intracellular Ca2\+ homeostasis. Arch Biochem Biophys 1984;235: 343-50. (Pubitemid 15158793)
92. Scott GK, Atsriku C, Kaminker P, et al. Vitamin K3 (menadione)-induced oncosis associated with keratin 8 phosphorylation and histone H3 arylation. Mol Pharmacol 2005;68: 606-15. (Pubitemid 41206014)
93. Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother 2003; 57: 145-55. (Pubitemid 36740460)
94. Arrick BA, Griffith OW, Cohn ZA. Glutathione depletion sensitizes tumor cells to oxidative cytolysis. J Biol Chem 1982;257: 1231-7. (Pubitemid 12121636)
95. Rando OJ, Zhao K, Crabtree GR. Searching for a function for nuclear actin. Trends Cell Biol 2000;10: 92-7. (Pubitemid 30110691)
96. Rando OJ, Zhao K, Janmey P, Crabtree GR. Phosphatidylinositol-dependent actin filament binding by the SWI/SNF-like BAF chromatin remodelling complex. Proc Natl Acad Sci USA 2002;99: 2824-9. (Pubitemid 34240545)
97. Spencer VA, Costes S, Inman JL, et al. Depletion of nuclear actin is a key mediator of quiescence in epithelial cells. J Cell Sci 2011;24: 123-32.
98. Thériot JA, Mitchison TJ. Actin microfilament dynamics in locomoting cells. Nature 1991;352: 126-31. (Pubitemid 21896707)
99. Akman SA, Dietrich M, Chlebowski R, et al. Modulation of cytotoxicity of menadione sodium bisulfite versus leukemia L1210 by the acid-soluble thiol pool. Cancer Res 1985;45: 5257-62. (Pubitemid 16200830)
100. Carbonera D, Azzone GF. Permeability of inner mitochondrial membrane and oxidative stress. Biochim Biophys Acta 1988;943: 245-55.
101. Gilloteaux J, Eze N, Jamison JM, et al. A rare, human prostate oncocyte cell originates from the prostatic carcinoma (DU145) cell line. Ultrastruct Pathol 2013;37: 1-9.
102. Kabsch W, Mannherz HG, Suck D. Three-dimensional structure of the complex of actin and DNAse I at 4.5A ° resolution. EMBO J 1985;4: 2113-18.
103. Kabsch W, Mannherz HG, Suck D, et al. Atomic structure of the actin: DNase I complex. Nature 1990;347: 37-44.
104. Malorni W, Iosi F, Mirabelli F, Bellomo G. Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells: Alterations underlying surface bleb formation. Cell Biol Interact 1991;80: 217-36.
105. Burtnick LD, Chan KW. Deoxyribonuclease I binding masks the major tryptic cleavage sites of actin. Life Sci 1980;26: 1323-7. (Pubitemid 10048008)
106. Thiry M. DNase I-sensitive sites within the nuclear architecture visualized by immunoelectron microscopy. DNA Cell Biol 1991;10: 169-80.
107. Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26: 239-57.
108. Gewies A, Rocklin OW, Cohen MB. Ceramide induces cell death in the human prostatic carcinoma cell lines PC3 and DU145 but does not seem to be involved in Fas-mediated apoptosis. Lab Invest 2000;80: 671-6. (Pubitemid 30340651)
109. Franke WW, Kartenbeck J. Outer mitochondrial membrane continuous with endoplasmic reticulum. Protoplasma 1971;73: 35-41.
110. Baumgartner HK, Gerasimenko JV, Thorne C, et al. Calcium elevation in mitochondria is the main Ca2\+ requirement for mitochondrial permeability transition pore (mPTP) opening. J Biol Chem 2009;284: 20796-803.
111. Criddle DN, Gillies S, Baumgartner-Wilson HK, et al. Menadione-induced reactive oxygen species generation via redox cycling promotes apoptosis of murine pancreastic acinar cells. J Biol Chem 2006;281: 40485-92. (Pubitemid 46041851)
112. Melgar ML, Anadon A, Bello J. Effects of menadione on the cardiovascular system. Vet Hum Toxicol 1991;33: 110-14.
113. Hamasaki M, Furuta N, Matsuda A, et al. Autophagosomes form at ER-mitochondria contact sites. Nature 2013;495: 389-93.
114. Hallman A, Milczarek R, Lippinski M, et al. Fast perinuclear clustering of mitochondria in oxidatively stressed human choriocarcinoma cells. Folia Morphol 2004;63: 407-12. (Pubitemid 39654619)
115. Noto V, Taper HS, Jiang YH, et al. Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphtoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action. Cancer 1989;63: 901-6. (Pubitemid 19063198)
116. Von Gruenigen VE, Jamison JM, et al. The in vitro antitumor activity of vitamins C and K3 against ovarian carcinoma. Anticancer Res 2003;23: 3279-87. (Pubitemid 36975424)
117. Bonilla-Porras AR, Jimenez-Del Rio M, Velez-Pardo C. Vitamin K3 and vitamin C alone or in combination induced apoptosis in leukemia cells by a similar oxidative stress signalling mechanism. Cancer Cell Int 2011;11: 19.
118. Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol 1927;8: 519-30.
119. Warburg O. On respiratory impairment in cancer cells. Science 1956;124: 369-70.
120. Bernhard W. Drug-induced changes in the interphase nucleus. Adv Cytopharmacol 1971;1: 49-67.
121. Simard R. The nucleus: Action of chemical and physical agents. Int Rev Cytol 1970;28: 169-211.
122. Simard R, Bernhard W. Le phénomène de la ségrégation nucléolaire: Spécificité d'action de certains antimétabolites. Int J Cancer 1966;1: 463-79.
123. Smetana K, Potme?sil M. Ring shaped nucleoli in liver cells of rats after treatment with actinomycin D. Z Zellforsch Mikrosk Anat 1968;92: 62-9.
124. Bassleer R, Goessens G, Lepoint A, et al. Contribution à l'étude des effets d'agents antimitotiques sur des cellules animales normales ou ancéreuses. Analyses cytologiques et cytochimiques quantitatives. Bull Mém Acad Roy Med Belg 1967;13: 496-502.
125. Daoust R, Amano H. Ribonuclease and deoxiribonuclease activities in experimental and human tumors by the histochemical substrate film method. Cancer Res 1963;23: 131-4.
126. Chobert MN, Pouchelet M, Anteunis A, et al. Nucleolar lesions induced by ribonuclease in living cultured cells. Biol Cell 1983;49: 19-28.
127. Cogliati R, Gautier A. Demonstration of DNA and polysaccharides using a new "Schiff type" reagent. C R Acad Sci Hebd Séances Acad Sci D 1973;276: 3041-4.
128. Smetana K, Busch H. Studies on the ultrastructure of the nucleoli of the Walker tumor and rat liver. Cancer Res 1964;24: 537-57.
129. Ervin E, Jamison JM, Gilloteaux J, et al. Characterization of the early events in vitamin C and K3-induced death of human bladder tumor cells. Scanning 1998;20: 210-11. (Pubitemid 128496014)
130. Monneron A, Bernhard W. Fine structural organization of the interphase nucleus in some mammalian cells. J Ultrastruct Res 1969;27: 266-88.
131. Moyne G. Feulgen-derived techniques for electron microscopical cytochemistry of DNA. J Ultrastruct Res 1973;45: 102-23.
132. Fakan S, Puvion E. The ultrastructural visualization of nucleolar and extranucleolar RNA synthesis and distribution. Int Rev Cytol 1980;65: 255-99. (Pubitemid 11066480)
133. Saitoh N, Spahr CS, Patterson SD, et al. Proteomic analysis of interchromatin granule clusters. Mol Biol Cell 2004;15: 3876-90. (Pubitemid 38989721)
134. Fraschini A, Albi E, Gahan PB, Viola-Magni MP. TEM cytochemical study of the localization of phospholipids in interphase chromatin in rat hepatocytes. Histochemistry 1992;97: 225-35.
135. Wassef M. A cytochemical study of interchromatin granules. J Ultrastruct Res 1979;69: 121-33. (Pubitemid 10196451)
136. Johnston JA,Ward CL, Kopito RR. Aggresomes: A cellular response to misfolded proteins. J Cell Biol 1990;143: 1883-98.
137. Johnston JA, Illing ME, Kopito RR. Cytoplasmic dynein/dynactin mediates the assembly of aggresomes. Cell Motil Cytoskeleton 2002;53: 26-38. (Pubitemid 34984442)
138. Gilloteaux J, Jennes L, Stoeckel ME, Vanderhaeghen J-J. Focal ellipsoid deposits in the atrial myocytes of Syrian hamster. Ultrastruct Pathol 1994;18: 221-7. (Pubitemid 24131631)
139. Wyllie AH. Apoptosis: An overview. Brit Med Bull 1997; 53: 451-65. (Pubitemid 27397303)
140. Falcieri E, Gobbi P, Zamai L, Vitale M. Ultarstructural features of apoptosis. Scanning Microsc Intl 1994a;8: 653-66.
141. Saraste A. Morphologic criteria and detection of apoptosis. Herz 1999;24: 189-95. (Pubitemid 29254659)
142. Biggiogera M, Bottone MG, Pelliciari C. Nuclear RNA is extruded from apoptotic cells. J Histochem Cytochem 1998; 46: 999-1005. (Pubitemid 28402480)
143. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Fine structural organization of the interphase nucleus in some mammalian cells. J Ultrastruct Res 1995;27: 266-88.
144. Deter RL, Baudhuin P, De Duve C. Participation of lysosomes in cellular autophagy induced in rat liver by glucagon. J Cell Biol 1967;35: C11-16.
145. Ericsson JLE. Mechanism of cellular autophagy. In: Dingle JT, Fell HB, eds. Lysosomes in biology and pathology. Amsterdam: North-Holland Publishing Co, 1969;345-94.
146. Allison AC. Lysosomes and cancer. In: Dingle JT, Fell HB, eds. Lysosomes in biology and pathology. Amsterdam: North Holland Publ Co., 1990;178-204.
147. Levine B, Yuan J. Autophagy in cell death: An innocent convict? J Clin Invest 2005;115: 2679-88. (Pubitemid 41434392)
148. Wyllie AH, Beattie GJ, Hargreaves AD. Chromatin changes in apoptosis. Histochem J 1981;13: 681-92. (Pubitemid 11014660)
149. Arends MJ, Morris RG, Wyllie AH. Apoptosis. The role of the endonuclease. Am J Pathol 1990;136: 593-608. (Pubitemid 20105927)
150. Walker NI, Harmon BV, Gobé GC, Kerr JF. Patterns of cell death. Methods Achiev Exp Pathol 1988;13: 18-54.
151. Velkey JM, Bernanke DH. Apoptosis during coronary artery orifice development in the chick embryo. Anat Rec 2001;262: 310-17. (Pubitemid 32178788)
152. Tavassoli M, Crosby WH. Fate of the nucleus of the marrow erythroblast. Science 1973;179: 912-13.
153. Sonoda Y, Sasaki K, Suda M, et al. Effects of colchicine on the enucleation of erythroid cells and macrophages in the liver of mouse embryos: Ultrastructural and threedimensional studies. Anat Rec 1998;251: 290-6. (Pubitemid 28298496)
154. Aumü ller G, Seitz J, Riva A. Functional morphology of prostate gland. In: Riva A, Testa-Riva F, Motta PM, eds. Ultrastructure of male urogenital glands. Boston (MA): Kluwer Acad, 1994;61-112.
155. Kudo S. Differentiation of Clara cells and pneumocytes of the rat by means of enzyme-and immunohistochemistry. Anat Rec 1994;238: 49-56. (Pubitemid 24002448)